These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 34059350)

  • 1. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
    Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of FIGO staging defined by combining MRI and [
    Raffa S; Lanfranchi F; Satragno C; Giannelli F; Marcenaro M; Coco A; Cena SE; Sofia L; Marini C; Mammoliti S; Levaggi A; Tagliafico AS; Sambuceti G; Barra S; Morbelli S; Belgioia L; Bauckneht M
    Curr Probl Cancer; 2023 Dec; 47(6):101007. PubMed ID: 37684197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study.
    Knoth J; Pötter R; Jürgenliemk-Schulz IM; Haie-Meder C; Fokdal L; Sturdza A; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Wiebe E; Rai B; Cooper R; van der Steen-Banasik E; van Limbergen E; Pieters BR; Sundset M; Tan LT; Nout RA; Tanderup K; Kirisits C; Nesvacil N; Lindegaard JC; Schmid MP
    Gynecol Oncol; 2020 Oct; 159(1):136-141. PubMed ID: 32798000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Less Than Whole Uterus Irradiation for Locally Advanced Cervical Cancer Maintains Locoregional Control and Decreases Radiation Dose to Bowel.
    Kozak MM; Koenig JL; von Eyben R; Kidd EA
    Pract Radiat Oncol; 2019 Mar; 9(2):e164-e171. PubMed ID: 30395974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes and Prognostic Factors in Stage III C Cervical Cancer Patients Treated with Radical Radiotherapy or Radiochemotherapy.
    Zhang W; Yu H; Xiu Y; Meng F; Wang Z; Zhao K; Wang Y; Chen Z; Liu J; Chen J; Sun B
    Technol Cancer Res Treat; 2024; 23():15330338241254075. PubMed ID: 38720626
    [No Abstract]   [Full Text] [Related]  

  • 7. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
    Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
    BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
    Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
    Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
    Chung YL; Horng CF; Lee PI; Chen FL
    BMC Cancer; 2016 Mar; 16():179. PubMed ID: 26940959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.
    Yang E; Huang S; Ran X; Huang Y; Li Z
    BMC Cancer; 2021 Feb; 21(1):203. PubMed ID: 33639874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overall survival in patients with FIGO stage IVA cervical cancer.
    Schiff JP; Mintz R; Cohen AC; Huang Y; Thaker P; Massad LS; Powell M; Mutch D; Schwarz JK; Markovina ST; Grigsby PW
    Gynecol Oncol; 2022 Aug; 166(2):292-299. PubMed ID: 35691754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended field chemoradiation for cervical cancer patients with histologically proven para-aortic lymph node metastases after laparaoscopic lymphadenectomy.
    Marnitz S; Schram J; Budach V; Sackerer I; Vercellino GF; Sehouli J; Köhler C
    Strahlenther Onkol; 2015 May; 191(5):421-8. PubMed ID: 25413986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed Tomography-Planned High-Dose-Rate Brachytherapy for Treating Uterine Cervical Cancer.
    Zolciak-Siwinska A; Gruszczynska E; Bijok M; Jonska-Gmyrek J; Dabkowski M; Staniaszek J; Michalski W; Kowalczyk A; Milanowska K
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):87-92. PubMed ID: 27375169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
    Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly Image Guidance in Patients With Cervical Cancer Treated With Intensity-Modulated Radiation Therapy: Results of a Large Cohort Study.
    Zeng Z; Wang W; Yan J; Liu D; Zhang F; Hu K
    Cancer Med; 2024 Sep; 13(18):e70269. PubMed ID: 39351618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery.
    Zhang X; Lv Z; Xu X; Yin Z; Lou H
    BMC Cancer; 2020 Jul; 20(1):664. PubMed ID: 32678039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent.
    Narayan K; Fisher RJ; Bernshaw D; Shakher R; Hicks RJ
    Int J Gynecol Cancer; 2009 Jul; 19(5):912-8. PubMed ID: 19574784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.